Chelation cures "dangerously misleading"

Vogel, Lauren
November 2010
CMAJ: Canadian Medical Association Journal;11/23/2010, Vol. 182 Issue 17, pE756
Academic Journal
The article reports that the U.S. Food and Drug Administration (FDA) has warned the eight companies selling chelation therapies to treat a range of serious conditions including autism spectrum disorders, heart diseases, and Parkinson diseases to stop marketing the products or face a legal action.


Related Articles

  • FDA Warning Targets OTC Chelation Products. Voelker, Rebecca // JAMA: Journal of the American Medical Association;11/17/2010, Vol. 304 Issue 19, p2112 

    The article reports on the warning issued by the U.S. Food and Drug Administration (FDA) to companies that promoting over-the-counter chelation products as treatments for autism, cardiovascular disease, and other serious health problems are dangerous and illegal.

  • FDA reconsidering the safety of mercury amalgams fillings.  // Hudson Valley Business Journal;7/28/2008, Vol. 19 Issue 30, p18 

    The article highlights the new diagnostic testing and chelation therapy for mercury and other heavy metal introduced by the Institute for Progressive Medicine in Hudson Valley, New York. The author stated that the initiative is in response to the Food and Drug Administration (FDA)...

  • New Study on Chelation Therapy Proves Controversial. Elliott, William T. // Infectious Disease Alert;May2013 Pharmacology Watch, p1 

    The article offers information on a study that examined chelation therapy in patients with cardiovascular disease. The study evaluated the value of chelation enrolled more than 1,700 patients with a history of myocardial infarction. It provides evidence to guide further research but the study's...

  • Federal Regulation of Unapproved Chelation Products. Lee, Charles E. // Journal of Medical Toxicology;Dec2013, Vol. 9 Issue 4, p313 

    Chelation products can be helpful in the treatment of metal poisoning. However, many unapproved products with unproven effectiveness and safety are marketed to consumers, frequently via the internet. This paper describes the primary responsibility of the Health Fraud and Consumer Outreach Branch...

  • Autism-Chelation Study Canceled. Klotter, Jule // Townsend Letter;Jan2009, Issue 306, p33 

    The article reports on the cancellation of the National Institute of Mental Health (NIMH) of a scheduled trial to evaluate succimer chelation therapy in September 2008. The NIMH trial was designed to test the therapy on recruited autistic children with non-toxic levels of mercury or lead in...

  • AUTISM INC. Hannaford, Alex // Texas Observer: A Journal of Free Voices;Feb2013, Vol. 105 Issue 2, p16 

    The article focuses on autism spectrum disorder (ASD) among children. According to the U.S. Centers for Disease Control and Prevention one in 88 children in the U.S. suffer from ASD. National Academy of Sciences put this figure as a result of more awareness about autism among parents and...

  • Prescription ads next on FDA list. Colford, S.W. // Advertising Age;8/26/91, Vol. 62 Issue 35, p32 

    Examines Food & Drug Administration (FDA) plans to tighten regulations on drug advertising and various promotional practices. Principal concerns of Commissioner David Kessler; Present regulations of consumer ads for prescription drugs.

  • Over-the-counter drugs. Sommi Jr., R.W. // Current Health 2;May92, Vol. 18 Issue 9, p21 

    Discusses the differences between prescription and nonprescription drugs (also called over-the-counter, or OTC, drugs). Role of the US Food and Drug Administration (FDA); OTC drugs for self-limiting illnesses such as the common cold; The FDA's concern about side effects, clear instructions and...

  • The FDA safeguarding. Kowalski, Kathiann M. // Current Health 2;Jan1996, Vol. 22 Issue 5, p20 

    Presents the work and duties of the Food and Drug Administration (FDA) in the United States. Origin of the agency; Rules followed on food standard inspection; Presence of food chemicals; Safety programs of FDA; Actions of the agency in the presence of problems; Nutrition labeling and Education...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics